The Site Perspective: COVID-19 and the movement towards Direct-to-Patient trials Read More › 23 Mar, 2020
The Ultimate Guide To Scenario Planning Clinical Supply Decisions Many facets of a clinical trial are unpredictable. Patient enrollment can vary widely... Read More › 18 Dec, 2019
Power of Excel & The Case for Moving Beyond the Beloved Tool for Clinical Trial Forecasting Read More › 10 Oct, 2019
A Site-Based Approach to Drug Accountability in Clinical Trials When it comes to drug accountability, there is no “one size fits all” approach. Read More › 2 Oct, 2019
Should Clinical Supply Planners be Statistical Experts? Spoiler alert. Clinical Supply Planners (CSPs) shouldn’t require a PhD in math, but p... Read More › 18 Sep, 2019
As Clinical Trials Evolve, Will Your Systems Keep Up? Have you ever worked on a study that went exactly as planned? Read More › 21 Aug, 2019
Top 5 Questions to Ask When Considering RTSM Systems for Phase 1 Clinical Trials Traditionally, RTSM systems (also known as IRT or IxRs), have been used for Phase 2 a... Read More › 31 Jul, 2019
Top 6 Benefits of Leveraging an RTSM for Investigator Initiated Trials (IITs) Investigator Initiated Trials (IITs), sometimes called Investigator Sponsored Trials ... Read More › 17 Jul, 2019
/4c-scenario-01.png)
.jpg)
.jpg)
